RNU6-1016P

Across TCGA pan-cancer cohorts, RNU6-1016P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNU6-1016P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-1016P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-1016P expression acts as an unfavorable survival marker, although some lineages such as ACC and READ show a favorable association.

ACC, UVM, and READ are the cancer types where RNU6-1016P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	1.000	0.752	.005	37	view →
UVM	DFS	Tertile	III,IV	0.230	0.774	.003	34	view →
READ	OS	Tertile	IV	0.959	0.461	.001	31	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	30	view →
THCA	DFS	Median	II,III,IV	0.791	0.934	.003	30	view →
HNSC	OS	Median	All	0.450	0.323	.004	25	view →
DLBC	DFS	Quartile	III,IV	0.074	0.984	.008	22	view →
SARC	OS	Tertile	All	0.453	0.795	.002	13	view →
STAD	OS	Tertile	All	0.788	0.368	.020	9	view →
ESCA	OS	Median	All	0.449	1.000	.011	8	view →
SKCM	OS	Quartile	III,IV	0.772	0.506	.001	8	view →
LAML	DFS	Median	All	0.679	0.437	.022	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RNU6-1016P–ACC (OS)

Open the ACC breakdown →